Published in J Gen Virol on July 01, 1992
A plasmid-based reverse genetics system for influenza A virus. J Virol (1996) 4.33
Sequence-specific binding of the influenza virus RNA polymerase to sequences located at the 5' ends of the viral RNAs. J Virol (1994) 3.41
Recombinant influenza virus polymerase: requirement of both 5' and 3' viral ends for endonuclease activity. J Virol (1994) 3.39
Identification of an RNA binding region within the N-terminal third of the influenza A virus nucleoprotein. J Virol (1995) 1.76
Polyadenylation of influenza virus mRNA transcribed in vitro from model virion RNA templates: requirement for 5' conserved sequences. J Virol (1998) 1.68
Attenuation of influenza A virus mRNA levels by promoter mutations. J Virol (1998) 1.63
A hairpin loop at the 5' end of influenza A virus virion RNA is required for synthesis of poly(A)+ mRNA in vitro. J Virol (1999) 1.58
A 48-amino-acid region of influenza A virus PB1 protein is sufficient for complex formation with PA. J Virol (1995) 1.52
The RNA polymerase of influenza virus, bound to the 5' end of virion RNA, acts in cis to polyadenylate mRNA. J Virol (1998) 1.52
Mutational analysis of influenza A virus nucleoprotein: identification of mutations that affect RNA replication. J Virol (1999) 1.47
Serine 3 is critical for phosphorylation at the N-terminal end of the nucleoprotein of influenza virus A/Victoria/3/75. J Virol (1996) 1.16
The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene (1985) 3.42
Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J (1994) 3.26
Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology (1983) 3.04
Influenza virus matrix protein is the major driving force in virus budding. J Virol (2000) 2.49
Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol (2000) 2.48
Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance. Nucleic Acids Res (1986) 2.45
Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene (1980) 2.44
Identification of new polypeptide species (48-55K) immunoprecipitable by antiserum to purified large T antigen and present in SV40-infected and -transformed cells. Virology (1979) 2.38
Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J Virol (1989) 2.17
Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J Virol (1995) 2.16
Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci U S A (2001) 2.04
Efficient transformation of mammalian cells with constructs containing a puromycin-resistance marker. Gene (1988) 2.03
Complex structure of the nuclear translocation signal of influenza virus polymerase PA subunit. J Gen Virol (1994) 2.03
The mammalian staufen protein localizes to the somatodendritic domain of cultured hippocampal neurons: implications for its involvement in mRNA transport. J Neurosci (1999) 2.03
Individual expression of influenza virus PA protein induces degradation of coexpressed proteins. J Virol (1995) 2.02
Distinct regions of influenza virus PB1 polymerase subunit recognize vRNA and cRNA templates. EMBO J (1999) 2.00
Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids. J Virol (1996) 1.98
PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators. J Virol (2001) 1.98
Genetic variability of Hong Kong (H3N2) influenza viruses: spontaneous mutations and their location in the viral genome. Gene (1980) 1.95
Monoclonal antibodies against influenza virus PB2 and NP polypeptides interfere with the initiation step of viral mRNA synthesis in vitro. J Virol (1994) 1.93
Efficient formation of influenza virus-like particles: dependence on the expression levels of viral proteins. J Gen Virol (1999) 1.89
Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. Nucleic Acids Res (1996) 1.89
Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies. Virology (2000) 1.87
Ultrastructural and functional analyses of recombinant influenza virus ribonucleoproteins suggest dimerization of nucleoprotein during virus amplification. J Virol (2000) 1.86
Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology (1985) 1.84
Synthesis of biologically active influenza virus core proteins using a vaccinia virus-T7 RNA polymerase expression system. J Gen Virol (1994) 1.83
Host nuclear proteins expressed in simian virus 40-transformed and -infected cells. Proc Natl Acad Sci U S A (1980) 1.82
The amino-terminal one-third of the influenza virus PA protein is responsible for the induction of proteolysis. J Virol (1996) 1.79
Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo. J Gen Virol (1997) 1.79
Identification of an RNA binding region within the N-terminal third of the influenza A virus nucleoprotein. J Virol (1995) 1.76
Influenza virus naked RNA can be expressed upon transfection into cells co-expressing the three subunits of the polymerase and the nucleoprotein from simian virus 40 recombinant viruses. J Gen Virol (1993) 1.74
A human sequence homologue of Staufen is an RNA-binding protein that is associated with polysomes and localizes to the rough endoplasmic reticulum. Mol Cell Biol (1999) 1.74
The influenza A virus PB2 polymerase subunit is required for the replication of viral RNA. J Virol (1997) 1.71
Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations). Virology (1994) 1.69
The replication activity of influenza virus polymerase is linked to the capacity of the PA subunit to induce proteolysis. J Virol (2000) 1.69
CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene (2010) 1.65
miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ (2010) 1.64
Evolution of the nucleotide sequence of influenza virus RNA segment 7 during drift of the H3N2 subtype. Gene (1983) 1.64
Heterogeneity of the mutation rates of influenza A viruses: isolation of mutator mutants. J Virol (1992) 1.61
Frame shift mutations as a novel mechanism for the generation of neutralization resistant mutants of human respiratory syncytial virus. EMBO J (1990) 1.59
Nuclear transport of influenza virus polymerase PA protein. Virus Res (1992) 1.59
Three-dimensional reconstruction of a recombinant influenza virus ribonucleoprotein particle. EMBO Rep (2001) 1.55
Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Gene (1986) 1.53
Characterization of influenza virus PB1 protein binding to viral RNA: two separate regions of the protein contribute to the interaction domain. J Virol (1999) 1.52
Phenotypic hiding: the carryover of mutations in RNA viruses as shown by detection of mar mutants in influenza virus. J Virol (1989) 1.50
Premature stop codons in the G glycoprotein of human respiratory syncytial viruses resistant to neutralization by monoclonal antibodies. J Virol (1991) 1.50
Antigenic structure of human respiratory syncytial virus fusion glycoprotein. J Virol (1998) 1.50
Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J Gen Virol (1997) 1.49
Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes: sequence evolution and prediction of possible functional domains. Virus Res (1989) 1.49
pac gene as efficient dominant marker and reporter gene in mammalian cells. Methods Enzymol (1992) 1.48
Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J Exp Med (1998) 1.48
The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation. Nucleic Acids Res (1997) 1.48
Mutational analysis of influenza A virus nucleoprotein: identification of mutations that affect RNA replication. J Virol (1999) 1.47
Lung histopathological findings in fatal pandemic influenza A (H1N1). Med Intensiva (2011) 1.46
Mutational analysis of the influenza virus A/Victoria/3/75 PA protein: studies of interaction with PB1 protein and identification of a dominant negative mutant. J Gen Virol (1996) 1.43
Mutational analysis identifies functional domains in the influenza A virus PB2 polymerase subunit. J Virol (1996) 1.38
Characterization of a human astrovirus serotype 2 structural protein (VP26) that contains an epitope involved in virus neutralization. Virology (1994) 1.37
Antiserum to polyacrylamide gel-purified simian virus 40 T antigen. Virology (1978) 1.36
Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture. J Virol (1990) 1.35
Analysis of genetic variability in human respiratory syncytial virus by the RNase A mismatch cleavage method: subtype divergence and heterogeneity. Virology (1990) 1.33
The PA influenza virus polymerase subunit is a phosphorylated protein. J Gen Virol (1998) 1.33
Interaction of influenza virus NS1 protein and the human homologue of Staufen in vivo and in vitro. Nucleic Acids Res (1999) 1.32
Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus. Virology (1997) 1.31
Isolation of cross-reactive, subtype-specific monoclonal antibodies against influenza virus HA1 and HA2 hemagglutinin subunits. Arch Virol (1987) 1.31
Regulated M1 mRNA splicing in influenza virus-infected cells. J Gen Virol (1991) 1.28
Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans. J Gen Virol (2000) 1.28
Replication of orthomyxoviruses. Adv Virus Res (1999) 1.27
Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus. J Virol (1990) 1.26
Participation of cytoskeletal intermediate filaments in the infectious cycle of human respiratory syncytial virus (RSV). Virus Res (1988) 1.25
The synthesis of influenza virus negative-strand RNA takes place in insoluble complexes present in the nuclear matrix fraction. Virus Res (1990) 1.24
Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis. Cell Death Differ (2011) 1.23
Nucleotide sequence of the fusion and phosphoprotein genes of human respiratory syncytial (RS) virus Long strain: evidence of subtype genetic heterogeneity. Virus Res (1988) 1.23
The three subunits of the polymerase and the nucleoprotein of influenza B virus are the minimum set of viral proteins required for expression of a model RNA template. Virology (1997) 1.22
Bordetella bronchiseptica pneumonia in a patient with AIDS. Thorax (1994) 1.22
Analysis of genetic variability and mapping of point mutations in influenza virus by the RNase A mismatch cleavage method. Proc Natl Acad Sci U S A (1988) 1.21
An antigen-binding assay to determine the specificity of monoclonal antibodies against influenza virus and mapping of epitopes. J Virol Methods (1986) 1.21
Degradation of cellular mRNA during influenza virus infection: its possible role in protein synthesis shutoff. J Gen Virol (1992) 1.19
Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein. J Gen Virol (1993) 1.19
Influenza virus NS1 protein alters the subnuclear localization of cellular splicing components. J Gen Virol (1995) 1.18